Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Bristol-Myers Squibb Co. (BMY)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
3 new
Instablogs
StockTalks
Sentiment
Comments
33 new
News & PR
Market Currents
Buzz
Twitter: BMY
Coverage
Top Authors
Cramer
1 new
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Monday Options Update: MJN, BMY, FTR & FDO
Andrew Wilkinson
•
Nov 16
•
Comment!
Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza
R. Saito
•
Nov 16
•
Comment!
Wall Street Breakfast: Must-Know News
Suzanne Miller
•
Nov 16
•
32 Comments
Big Pharma Willing to Pay for Biotech Innovation
The Burrill Report
•
Nov 15
•
Comment!
The Real Price of Big Pharma's Huge Fines
Derek Lowe
•
Nov 10
•
6 Comments
10 Dividend Stocks for Enterprising Investors
Benjamin Clark
•
Nov 06
•
28 Comments
More articles on BMY »
Latest Transcript
Bristol-Myers Squibb Co. Q3 2009 Earnings Call Transcript
Thu October 22, 2009
More transcripts on BMY »
Cramer
Cramer's Lightning Round - The Only Water Stock Worth Buying (11/10/09)
Wed November 11, 2009
Cramer's Mad Money - Hey Big Spenders (11/5/09)
Fri November 6, 2009
Cramer's Mad Money - 8 Stocks that Measure the Market (11/3/09)
Wed November 4, 2009
More Cramer on BMY »
Instablogs
Healthcare News Recap
Fri November 6, 2009
•
M. E. Garza
•
Comment!
Monday's Rx-Recap (11-02-09)
Tue November 3, 2009
•
M. E. Garza
•
Comment!
Kendle International Healthcare
Mon November 2, 2009
•
Michael Michaud
•
Comment!
Write a post on BMY
|
More Instablogs on BMY »
Sentiment
What advice would you give to
BMY?
124 characters left
Market Currents
Monday 08:00 am
Bristol-Myers (BMY) says
it will spin off its stake
in its nutritionals division, Mead Johnson (MJN), in a deal that could net as much as $6.5B. Earlier this year, Bristol-Myers sold 17% of Mead Johnson in an IPO offering.
Comment!
More Market Currents on BMY »
What's your view of BMY?
Make sure you include BMY
140 characters left
|
Settings
thevoice@voicedup.com
: (
BMY
) trades at 10.3x '09E EPS (-31% S&P discount/-2% peer discount)
Mon, Aug 31, 2009
thevoice@voicedup.com
: (
BMY
) - aboveaverage pipeline, & shareholder value focused management team.
Wed, Aug 19, 2009
thevoice@voicedup.com
: (
BMY
) trades at 10.2x '09E EPS (5% disc to peers).
Fri, Jul 24, 2009
thevoice@voicedup.com
: (
BMY
) - (
MEDX
) Acquisition Complements Biopharma Strategy
Thu, Jul 23, 2009
More StockTalks on BMY »